Nicholas Stylopoulos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Bypass | 15 | 2020 | 740 | 3.410 |
Why?
|
Weight Loss | 11 | 2020 | 2396 | 1.130 |
Why?
|
Obesity | 14 | 2019 | 11700 | 1.090 |
Why?
|
Jejunum | 2 | 2018 | 528 | 1.030 |
Why?
|
Portal System | 1 | 2020 | 57 | 0.850 |
Why?
|
Hernia, Hiatal | 3 | 2005 | 75 | 0.750 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2018 | 84 | 0.730 |
Why?
|
Fundoplication | 3 | 2005 | 142 | 0.720 |
Why?
|
Intestinal Absorption | 4 | 2019 | 466 | 0.720 |
Why?
|
Time | 1 | 2018 | 530 | 0.640 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 173 | 0.640 |
Why?
|
Receptors, LDL | 1 | 2019 | 539 | 0.610 |
Why?
|
Laparoscopy | 11 | 2005 | 2068 | 0.590 |
Why?
|
Eating | 7 | 2019 | 1429 | 0.590 |
Why?
|
Thyroid Hormones | 1 | 2018 | 384 | 0.590 |
Why?
|
Blood Glucose | 5 | 2020 | 6125 | 0.570 |
Why?
|
Diet, Reducing | 1 | 2018 | 461 | 0.550 |
Why?
|
Gastroplasty | 2 | 2012 | 151 | 0.520 |
Why?
|
Metabolomics | 2 | 2019 | 1299 | 0.500 |
Why?
|
Ultrasonography, Interventional | 2 | 2020 | 1501 | 0.490 |
Why?
|
Bariatric Surgery | 4 | 2018 | 889 | 0.480 |
Why?
|
Cholesterol | 2 | 2019 | 2751 | 0.470 |
Why?
|
Basal Metabolism | 1 | 2012 | 165 | 0.440 |
Why?
|
Metabolism | 1 | 2012 | 231 | 0.420 |
Why?
|
Energy Metabolism | 6 | 2014 | 2953 | 0.390 |
Why?
|
Glucose | 5 | 2018 | 4016 | 0.380 |
Why?
|
Food Preferences | 1 | 2012 | 376 | 0.380 |
Why?
|
Weight Gain | 1 | 2019 | 2168 | 0.370 |
Why?
|
Obesity, Morbid | 1 | 2018 | 1081 | 0.360 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3116 | 0.330 |
Why?
|
Models, Animal | 3 | 2012 | 2263 | 0.310 |
Why?
|
Task Performance and Analysis | 2 | 2007 | 837 | 0.290 |
Why?
|
Endosonography | 3 | 2020 | 592 | 0.290 |
Why?
|
Mice, Obese | 2 | 2018 | 467 | 0.280 |
Why?
|
Body Weight | 6 | 2019 | 4804 | 0.270 |
Why?
|
Peptide Hormones | 1 | 2005 | 134 | 0.270 |
Why?
|
Educational Technology | 1 | 2004 | 58 | 0.270 |
Why?
|
Liver | 6 | 2020 | 7653 | 0.260 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 4958 | 0.260 |
Why?
|
Carrier Proteins | 1 | 2018 | 5257 | 0.260 |
Why?
|
Surgical Procedures, Operative | 2 | 2007 | 1937 | 0.250 |
Why?
|
Rats, Long-Evans | 2 | 2013 | 417 | 0.240 |
Why?
|
Esophageal Achalasia | 1 | 2002 | 95 | 0.220 |
Why?
|
Computer-Assisted Instruction | 2 | 2004 | 389 | 0.220 |
Why?
|
Hernia, Inguinal | 1 | 2002 | 199 | 0.210 |
Why?
|
Calorimetry, Indirect | 2 | 2012 | 170 | 0.210 |
Why?
|
Liver Circulation | 1 | 2020 | 171 | 0.210 |
Why?
|
Membrane Proteins | 1 | 2018 | 8262 | 0.200 |
Why?
|
Pilot Projects | 4 | 2020 | 7791 | 0.190 |
Why?
|
Clinical Competence | 2 | 2007 | 4632 | 0.190 |
Why?
|
Educational Measurement | 1 | 2007 | 1289 | 0.190 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 103 | 0.190 |
Why?
|
Adipose Tissue, White | 2 | 2018 | 347 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1454 | 0.180 |
Why?
|
Mucoproteins | 1 | 2017 | 53 | 0.170 |
Why?
|
Body Composition | 3 | 2019 | 2381 | 0.170 |
Why?
|
Follistatin | 1 | 2018 | 142 | 0.170 |
Why?
|
Bile Acids and Salts | 1 | 2019 | 327 | 0.170 |
Why?
|
Intestine, Small | 2 | 2018 | 1281 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 1 | 2002 | 590 | 0.170 |
Why?
|
Rats | 8 | 2014 | 25307 | 0.160 |
Why?
|
Robotics | 1 | 2003 | 834 | 0.160 |
Why?
|
Up-Regulation | 2 | 2019 | 4441 | 0.160 |
Why?
|
General Surgery | 2 | 2007 | 1671 | 0.160 |
Why?
|
Animals | 19 | 2019 | 170849 | 0.160 |
Why?
|
Adrenal Gland Neoplasms | 3 | 1997 | 748 | 0.150 |
Why?
|
Specimen Handling | 1 | 2020 | 693 | 0.150 |
Why?
|
Receptor, Melanocortin, Type 4 | 2 | 2014 | 125 | 0.150 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 1995 | 89 | 0.140 |
Why?
|
Adenoma, Pleomorphic | 1 | 1995 | 75 | 0.140 |
Why?
|
Mice | 9 | 2019 | 80803 | 0.140 |
Why?
|
Decision Support Techniques | 2 | 2002 | 2062 | 0.140 |
Why?
|
Computer Simulation | 3 | 2004 | 6120 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 619 | 0.140 |
Why?
|
Male | 24 | 2020 | 352465 | 0.130 |
Why?
|
Hyperphagia | 1 | 2014 | 118 | 0.130 |
Why?
|
Receptors, Glucagon | 1 | 2014 | 97 | 0.130 |
Why?
|
Digestion | 1 | 2013 | 68 | 0.130 |
Why?
|
Enteral Nutrition | 1 | 2019 | 711 | 0.130 |
Why?
|
Parotid Neoplasms | 1 | 1995 | 168 | 0.130 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 123 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 6 | 2014 | 8707 | 0.130 |
Why?
|
Glucose Transporter Type 1 | 1 | 2013 | 195 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 3 | 2007 | 1025 | 0.120 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2007 | 750 | 0.120 |
Why?
|
Stomach | 2 | 2007 | 689 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5015 | 0.110 |
Why?
|
Education, Medical | 1 | 2003 | 1625 | 0.110 |
Why?
|
Touch | 2 | 2003 | 306 | 0.110 |
Why?
|
Humans | 27 | 2020 | 686663 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1617 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2018 | 1294 | 0.100 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 23439 | 0.100 |
Why?
|
Middle Aged | 12 | 2020 | 216468 | 0.100 |
Why?
|
Duodenum | 1 | 2012 | 504 | 0.100 |
Why?
|
Feedback | 2 | 2003 | 728 | 0.090 |
Why?
|
Glycolysis | 1 | 2013 | 819 | 0.090 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18495 | 0.090 |
Why?
|
Markov Chains | 2 | 2002 | 992 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2013 | 2481 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 831 | 0.090 |
Why?
|
Food | 1 | 2012 | 708 | 0.090 |
Why?
|
Ghrelin | 2 | 2008 | 258 | 0.080 |
Why?
|
Critical Illness | 1 | 2019 | 2351 | 0.080 |
Why?
|
Sex Distribution | 2 | 2003 | 2436 | 0.080 |
Why?
|
Adrenalectomy | 3 | 1997 | 333 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2013 | 1240 | 0.080 |
Why?
|
Female | 15 | 2020 | 375459 | 0.080 |
Why?
|
Algorithms | 1 | 2007 | 13500 | 0.080 |
Why?
|
Body Temperature | 1 | 2009 | 801 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2013 | 20409 | 0.080 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1162 | 0.080 |
Why?
|
Feces | 2 | 2009 | 1358 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1352 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2019 | 10094 | 0.080 |
Why?
|
Diet | 3 | 2020 | 7351 | 0.070 |
Why?
|
Endoscopy | 2 | 2007 | 1688 | 0.070 |
Why?
|
Adenoma | 2 | 1996 | 2143 | 0.070 |
Why?
|
Computer Terminals | 1 | 2004 | 48 | 0.070 |
Why?
|
User-Computer Interface | 2 | 2003 | 1470 | 0.070 |
Why?
|
Muscle Fatigue | 1 | 2004 | 86 | 0.070 |
Why?
|
Aged | 9 | 2020 | 162271 | 0.070 |
Why?
|
Energy Intake | 2 | 2012 | 2121 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 1983 | 0.070 |
Why?
|
Data Display | 1 | 2004 | 187 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2012 | 6685 | 0.070 |
Why?
|
Homeostasis | 2 | 2012 | 3297 | 0.060 |
Why?
|
Hemostasis, Surgical | 1 | 2003 | 137 | 0.060 |
Why?
|
Electrocoagulation | 1 | 2003 | 173 | 0.060 |
Why?
|
Peristalsis | 1 | 2002 | 62 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1995 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4960 | 0.060 |
Why?
|
Models, Anatomic | 2 | 2007 | 699 | 0.060 |
Why?
|
History, 19th Century | 1 | 2005 | 746 | 0.060 |
Why?
|
Adult | 9 | 2019 | 211400 | 0.060 |
Why?
|
Arginine | 2 | 2017 | 943 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2003 | 323 | 0.060 |
Why?
|
Longevity | 1 | 2009 | 974 | 0.060 |
Why?
|
Proteins | 1 | 2017 | 6264 | 0.060 |
Why?
|
Signal Transduction | 3 | 2018 | 24351 | 0.050 |
Why?
|
Equipment Design | 3 | 2004 | 3653 | 0.050 |
Why?
|
Implants, Experimental | 2 | 2012 | 105 | 0.050 |
Why?
|
Esophagoscopy | 1 | 2003 | 414 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2003 | 667 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2003 | 5223 | 0.050 |
Why?
|
Manometry | 1 | 2002 | 427 | 0.050 |
Why?
|
Connective Tissue | 1 | 2002 | 361 | 0.050 |
Why?
|
Postoperative Period | 1 | 2005 | 1861 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2018 | 15597 | 0.050 |
Why?
|
Adrenal Gland Diseases | 2 | 1997 | 148 | 0.050 |
Why?
|
3T3-L1 Cells | 1 | 2018 | 223 | 0.040 |
Why?
|
Ornithine | 1 | 2017 | 74 | 0.040 |
Why?
|
Models, Economic | 1 | 2002 | 748 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6970 | 0.040 |
Why?
|
Gastric Emptying | 1 | 2019 | 228 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2002 | 1301 | 0.040 |
Why?
|
Deglutition Disorders | 1 | 2002 | 554 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 5981 | 0.040 |
Why?
|
Spleen | 1 | 2003 | 2570 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2002 | 1561 | 0.040 |
Why?
|
Age Distribution | 1 | 2003 | 2963 | 0.040 |
Why?
|
History, 20th Century | 1 | 2005 | 2878 | 0.040 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1943 | 0.040 |
Why?
|
Abdomen | 1 | 2002 | 1128 | 0.040 |
Why?
|
Prospective Studies | 1 | 2019 | 49071 | 0.040 |
Why?
|
Melanocortins | 1 | 2014 | 5 | 0.040 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 2014 | 20 | 0.040 |
Why?
|
Glucose Intolerance | 1 | 2018 | 581 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 6088 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12680 | 0.030 |
Why?
|
Ultrasonography | 1 | 2007 | 5876 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2003 | 16227 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1761 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2017 | 765 | 0.030 |
Why?
|
Quality of Life | 2 | 2002 | 10676 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3454 | 0.030 |
Why?
|
Benzazepines | 1 | 2014 | 334 | 0.030 |
Why?
|
Medical Records | 1 | 1997 | 1425 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2002 | 2769 | 0.030 |
Why?
|
Swine | 3 | 2007 | 5441 | 0.030 |
Why?
|
Recurrence | 1 | 2002 | 8198 | 0.030 |
Why?
|
Insulin Resistance | 2 | 2018 | 3808 | 0.030 |
Why?
|
Risk Assessment | 2 | 2003 | 23739 | 0.030 |
Why?
|
Down-Regulation | 1 | 2018 | 3226 | 0.020 |
Why?
|
Software | 1 | 2004 | 4314 | 0.020 |
Why?
|
Survival Rate | 2 | 2002 | 13606 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2006 | 19308 | 0.020 |
Why?
|
Health Status | 1 | 2002 | 4011 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2008 | 467 | 0.020 |
Why?
|
Sex Factors | 1 | 2002 | 10926 | 0.020 |
Why?
|
Electromagnetic Phenomena | 1 | 2007 | 153 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1955 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13807 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6669 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2003 | 60991 | 0.020 |
Why?
|
Dietary Fats | 1 | 2014 | 2078 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2787 | 0.020 |
Why?
|
Age Factors | 1 | 2002 | 19295 | 0.020 |
Why?
|
Incidence | 1 | 2003 | 20496 | 0.020 |
Why?
|
Mitochondria | 1 | 2017 | 3602 | 0.020 |
Why?
|
Motor Activity | 1 | 2014 | 2817 | 0.020 |
Why?
|
Hospitalization | 1 | 2002 | 9304 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2006 | 552 | 0.010 |
Why?
|
Time Factors | 2 | 2003 | 42271 | 0.010 |
Why?
|
Hematocrit | 1 | 2003 | 643 | 0.010 |
Why?
|
Prognosis | 1 | 2003 | 28923 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2014 | 5167 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1997 | 15407 | 0.010 |
Why?
|
Cicatrix | 1 | 2006 | 655 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 974 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8895 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 14656 | 0.010 |
Why?
|
Necrosis | 1 | 2003 | 1664 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 19328 | 0.010 |
Why?
|
Myelolipoma | 1 | 1996 | 11 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2002 | 59331 | 0.010 |
Why?
|
Esophagus | 1 | 2002 | 1028 | 0.010 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 1996 | 147 | 0.010 |
Why?
|
Germany | 1 | 1997 | 852 | 0.010 |
Why?
|
Adolescent | 3 | 1997 | 84957 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 7027 | 0.010 |
Why?
|
Pheochromocytoma | 1 | 1996 | 339 | 0.010 |
Why?
|
Collagen | 1 | 2003 | 2712 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1996 | 571 | 0.010 |
Why?
|
Insulin | 1 | 2008 | 6521 | 0.010 |
Why?
|
Hyperplasia | 1 | 1996 | 1192 | 0.010 |
Why?
|
Length of Stay | 2 | 1997 | 6241 | 0.010 |
Why?
|
Cysts | 1 | 1996 | 619 | 0.010 |
Why?
|
Child | 1 | 2019 | 71361 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2805 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1997 | 3009 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 15075 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3687 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1997 | 67320 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 1997 | 1234 | 0.010 |
Why?
|
Pain, Postoperative | 1 | 1997 | 1516 | 0.000 |
Why?
|
Internship and Residency | 1 | 2004 | 5322 | 0.000 |
Why?
|
Disease-Free Survival | 1 | 1996 | 7195 | 0.000 |
Why?
|
Carcinoma | 1 | 1996 | 2353 | 0.000 |
Why?
|
Follow-Up Studies | 2 | 1997 | 39737 | 0.000 |
Why?
|
Health Care Costs | 1 | 1997 | 3159 | 0.000 |
Why?
|
Analgesics, Opioid | 1 | 1996 | 3037 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1996 | 6450 | 0.000 |
Why?
|
Hypertension | 1 | 1996 | 7941 | 0.000 |
Why?
|
Risk Factors | 1 | 1996 | 69278 | 0.000 |
Why?
|